A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6600344.pdf
Reference39 articles.
1. A'hern R, Smith I, Ebbs S (1993) Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens. Br J Cancer 67: 801–805
2. Batist G, Ramakrishnan G, Sekhar Rao C, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Krishnan Nair M, Hoelzer K, Tkaczuk K, Choi Park Y, Lee LW (2001) Reduced cardiotoxicity and preserved anti-tumour efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomised, multicenter trial of metastatic breast cancer. J Clin Oncol 19: 1444–1454
3. Bellott R, Auvrignon A, Leblanc T, Perel Y, Gandemer V, Bertrand Y, Mechinaud F, Bellenger P, Vernois J, Leverger G, Baruchel A, Robert J (2001) Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia. Cancer Chemother Pharmacol 47: 15–21
4. Bonfante V, Ferrari L, Brambilla C, Rossi A, Villani F, Crippa F, Valagussa P, Bonadonna G (1986) New anthracycline analogs in advanced breast cancer. Eur J Cancer Clin Oncol 22: 1379–1385
5. Bronchud MH, Howell A, Crowther D, Hopwood P, Souza L, Dexter TM (1989) The use of granulocyte colony stimulating factor to increase intensity of treatment with doxorubicin in patients with breast and ovarian cancer. Br J Cancer 60: 121–125
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07
2. A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer;BioData Mining;2024-02-21
3. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes;Artificial Cells, Nanomedicine, and Biotechnology;2023-08-18
4. Functionalized liposomes for targeted breast cancer drug delivery;Bioactive Materials;2023-06
5. Nanotechnological Modus Operandi for the Delivery of Cytotoxic Phytochemicals;Bioprospecting of Tropical Medicinal Plants;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3